chr10-89223710-C-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000336233.10(LIPA):c.796G>T(p.Gly266Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000806 in 1,612,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G266G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000336233.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPA | NM_000235.4 | c.796G>T | p.Gly266Ter | stop_gained | 7/10 | ENST00000336233.10 | NP_000226.2 | |
LIPA | NM_001127605.3 | c.796G>T | p.Gly266Ter | stop_gained | 7/10 | NP_001121077.1 | ||
LIPA | NM_001288979.2 | c.448G>T | p.Gly150Ter | stop_gained | 5/8 | NP_001275908.1 | ||
LIPA | XM_024448023.2 | c.796G>T | p.Gly266Ter | stop_gained | 7/10 | XP_024303791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPA | ENST00000336233.10 | c.796G>T | p.Gly266Ter | stop_gained | 7/10 | 1 | NM_000235.4 | ENSP00000337354 | P1 | |
LIPA | ENST00000428800.5 | c.796G>T | p.Gly266Ter | stop_gained | 6/7 | 1 | ENSP00000388415 | |||
LIPA | ENST00000371837.5 | c.628G>T | p.Gly210Ter | stop_gained | 6/9 | 2 | ENSP00000360903 | |||
LIPA | ENST00000456827.5 | c.448G>T | p.Gly150Ter | stop_gained | 5/8 | 3 | ENSP00000413019 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152040Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250494Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135620
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460720Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726720
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74248
ClinVar
Submissions by phenotype
Lysosomal acid lipase deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Feb 22, 2017 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | May 28, 2020 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2022 | Published functional studies found this variant is associated with reduced lysosomal acid lipase activity (Vinje T et al., 2018); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 23928541, 28881270, 29196158, 26252914, 22227072, 30684275, 8617513, 33857477, 8254026) - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 01, 2022 | - - |
Wolman disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2023 | This sequence change creates a premature translational stop signal (p.Gly266*) in the LIPA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIPA are known to be pathogenic (PMID: 23485521). This variant is present in population databases (rs267607218, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with lysosomal acid lipase (LAL) deficiency (PMID: 28881270, 30684275). ClinVar contains an entry for this variant (Variation ID: 78). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Cholesteryl ester storage disease Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 1996 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at